Hudson Bay Capital Management
RCKT icon

Hudson Bay Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Hudson Bay Capital Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-35,000
Closed -$123K – 1559
2025
Q4 		$123K Buy
35,000
+300
+0.9% +$1.03K ﹤0.01% 1003
2025
Q3 		$113K Buy
34,700
+7,300
+27% +$23K ﹤0.01% 1060
2025
Q2 		$67.1K Sell
27,400
-123,800
-82% -$627K ﹤0.01% 1246
2025
Q1 		$1.01M Buy
151,200
+37,700
+33% +$372K ﹤0.01% 925
2024
Q4 		$1.43M Buy
113,500
+48,500
+75% +$730K 0.01% 705
2024
Q3 		$1.2M Buy
+65,000
New +$1.33M ﹤0.01% 641

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Hudson Bay Capital Management's RCKT Position: Q1 2026 in Review

Hudson Bay Capital Management sold out of Rocket Pharmaceuticals (RCKT) in Q1 2026, closing a stake of 35,000 shares — an estimated $123K sold.

Hudson Bay Capital Management first reported a position in RCKT in Q3 2024 and held it in 6 quarters. The position peaked at $1.43M in Q4 2024. 199 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • Hudson Bay Capital Management reported no remaining Rocket Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Hudson Bay Capital Management sold 35,000 Rocket Pharmaceuticals shares in Q1 2026, an estimated $123K.
  • Hudson Bay Capital Management first reported a position in Rocket Pharmaceuticals in Q3 2024 and held it in 6 quarters.
  • Hudson Bay Capital Management's Rocket Pharmaceuticals position peaked at $1.43M in Q4 2024.
  • 199 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.